The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions-Reference-Cited by-同舟云学术

The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions

Published:2016-10-05 Issue:11 Volume:55 Page:1219-1224
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatol

Author:

Hassoun-Kheir Nasreen¹,Bergman Reuven¹,Weltfriend Sara¹

Affiliation:

1. Department of Dermatology; Rambam Medical Health Campus and The Bruce Rappaport Faculty of Medicine, Technion Institute of Technology; Haifa Israel

Publisher

Wiley

Subject

Dermatology

Reference39 articles.

1. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations;Aberer;Allergy,2003

2. Diagnosis of drug hypersensitivity - state of the art;Iancovici-Kidon;Harefuah,2002

3. Outcomes and safety of drug provocation tests;Un;Allergy Asthma Proc,2011

4. European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions;Barbaud;Contact Dermatitis,2001

5. Skin tests in the diagnosis of drug hypersensitivity reactions;Brockow;Curr Pharm Des,2008

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative review;Indian Journal of Skin Allergy;2024-04-24

2. Drug patch testing in Stevens-Johnson syndrome and toxic epidermal necrolysis;Annals of Allergy, Asthma & Immunology;2023-05

3. Saline Vehicle Increases the Ability of Drug Patch Test in Cutaneous Adverse Drug Reactions;Dermatology;2023

4. Cutaneous adverse drug eruption: the role of drug patch testing;International Journal of Dermatology;2022-10-27

5. Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions;Frontiers in Medicine;2022-10-13